Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
Latest reported ADPT revenue for 2026-06-30 was $142.4M. Net income was -$59.8M. ADPT currently screens at market cap $2.69B.
Use this ADPT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ADPT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ADPT SEC filings page. Lician reads the product cache first so this HTML stays unique to Adaptive Biotechnologies Corp even when a live quote feed is slow.
Latest cached year on this hub. Full ADPT income, balance, and cash tables.